Contraceptives – Time to become effective (if not used on the first day of period):
Immediate: IUD
2 days: Progestin-only pill (POP)
7 days: Combined oral contraceptive (COC), injection, implant, intrauterine system (IUS)

Intrauterine contraceptive devices include copper IUDs and levonorgestrel-releasing IUS. Both are over 99% effective. The IUD prevents fertilization by decreasing sperm motility, while the IUS prevents endometrial proliferation and thickens cervical mucus. Potential problems include heavier periods with IUDs and initial bleeding with the IUS. There is a small risk of uterine perforation, ectopic pregnancy, and infection. New IUS systems, such as Jaydess® and Kyleena®, have smaller frames and less levonorgestrel, resulting in lower serum levels and different rates of amenorrhea.

Weight loss before pregnancy
Lack of proper hydration
Disruption in electrolyte balance

Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.

The best course of action to reduce sedation in a patient taking mirtazapine at a low dose (e.g. 15mg) is to increase the dose (e.g. to 45mg). Adding an SSRI or advising the patient to take mirtazapine on alternate days would not be ideal options. Halving the dose of mirtazapine may even worsen daytime somnolence. Stopping mirtazapine and switching to another medication is not recommended if the patient has responded well to mirtazapine.

Mirtazapine: An Effective Antidepressant with Fewer Side Effects

Mirtazapine is an antidepressant medication that functions by blocking alpha2-adrenergic receptors, which leads to an increase in the release of neurotransmitters. Compared to other antidepressants, mirtazapine has fewer side effects and interactions, making it a suitable option for older individuals who may be more susceptible to adverse effects or are taking other medications.

Mirtazapine has two side effects that can be beneficial for older individuals who are experiencing insomnia and poor appetite. These side effects include sedation and an increased appetite. As a result, mirtazapine is typically taken in the evening to help with sleep and to stimulate appetite.

Overall, mirtazapine is an effective antidepressant that is well-tolerated by many individuals. Its unique side effects make it a valuable option for older individuals who may have difficulty sleeping or eating.

In this scenario, it is also advisable to use Amoxicillin.

Urinary tract infections (UTIs) are common in adults and can affect different parts of the urinary tract. The management of UTIs depends on various factors such as the patient’s age, gender, and pregnancy status. For non-pregnant women, local antibiotic guidelines should be followed if available. Trimethoprim or nitrofurantoin for three days are recommended by NICE Clinical Knowledge Summaries. However, if the patient is aged over 65 years or has visible or non-visible haematuria, a urine culture should be sent. Pregnant women with UTIs should be treated with nitrofurantoin, amoxicillin, or cefalexin for seven days. Trimethoprim should be avoided during pregnancy as it is teratogenic in the first trimester. Asymptomatic bacteriuria in pregnant women should also be treated to prevent progression to acute pyelonephritis. Men with UTIs should be offered a seven-day course of trimethoprim or nitrofurantoin unless prostatitis is suspected. A urine culture should be sent before antibiotics are started. Catheterised patients should not be treated for asymptomatic bacteria, but if symptomatic, a seven-day course of antibiotics should be given. Acute pyelonephritis requires hospital admission and treatment with a broad-spectrum cephalosporin or quinolone for 10-14 days. Referral to urology is not routinely required for men who have had one uncomplicated lower UTI.

A painless, firm lump in the eyelid is indicative of a chalazion or Meibomian cyst. This occurs when the Meibomian gland becomes blocked, resulting in the formation of a cyst. It is often a consequence of an internal stye (hordeolum internum). Although cysts may resolve on their own, they may require topical antibiotics if they become infected. The absence of pain and the prolonged history suggest that it is not an internal or external stye. Blepharitis and ectropion are unlikely to cause a lump in the eyelid.

Eyelid problems are quite common and can include a variety of issues. One such issue is blepharitis, which is inflammation of the eyelid margins that can cause redness in the eye. Another problem is a stye, which is an infection of the glands in the eyelids. Chalazion, also known as Meibomian cyst, is another eyelid problem that can occur. Entropion is when the eyelids turn inward, while ectropion is when they turn outward.

Styes can come in different forms, such as external or internal. An external stye is an infection of the glands that produce sebum or sweat, while an internal stye is an infection of the Meibomian glands. Treatment for styes typically involves hot compresses and pain relief, with topical antibiotics only being recommended if there is also conjunctivitis present. A chalazion, on the other hand, is a painless lump that can form in the eyelid due to a retention cyst of the Meibomian gland. While most cases will resolve on their own, some may require surgical drainage.

Although furosemide is effective in treating the symptoms of both acute and chronic heart failure, it does not provide any predictive advantages.

Drug Management for Chronic Heart Failure: NICE Guidelines

Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.

Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.

Monitoring FBC is crucial in patients taking clozapine as agranulocytosis/neutropenia, a potentially fatal side effect, can occur. It is imperative to rule out neutropenia in case of infections.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These medications have the advantage of significantly reducing extrapyramidal side-effects. However, they can also cause adverse effects such as weight gain, hyperprolactinaemia, and in the case of clozapine, agranulocytosis. The Medicines and Healthcare products Regulatory Agency has issued warnings about the increased risk of stroke and venous thromboembolism when antipsychotics are used in elderly patients. Examples of atypical antipsychotics include clozapine, olanzapine, risperidone, quetiapine, amisulpride, and aripiprazole.

Clozapine, one of the first atypical antipsychotics, carries a significant risk of agranulocytosis and requires full blood count monitoring during treatment. Therefore, it should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Adverse effects of clozapine include agranulocytosis, neutropaenia, reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

If aspirin and clopidogrel cannot be used after an ischaemic stroke, MR dipyridamole may be administered as the sole antiplatelet option. Warfarin and rivaroxaban may be considered, but are more suitable for patients with AF. Bisoprolol and enoxaparin are not antiplatelet medications.

The Royal College of Physicians (RCP) and NICE have published guidelines on the diagnosis and management of patients following a stroke. The management of acute stroke includes maintaining normal levels of blood glucose, hydration, oxygen saturation, and temperature. Blood pressure should not be lowered in the acute phase unless there are complications. Aspirin should be given as soon as possible if a haemorrhagic stroke has been excluded. Anticoagulants should not be started until brain imaging has excluded haemorrhage. Thrombolysis with alteplase should only be given if administered within 4.5 hours of onset of stroke symptoms and haemorrhage has been definitively excluded. Mechanical thrombectomy is a new treatment option for patients with an acute ischaemic stroke. NICE recommends thrombectomy for people who have acute ischaemic stroke and confirmed occlusion of the proximal anterior circulation demonstrated by computed tomographic angiography or magnetic resonance angiography. Secondary prevention includes the use of clopidogrel and dipyridamole. Carotid artery endarterectomy should only be considered if carotid stenosis is greater than 70% according to ECST criteria or greater than 50% according to NASCET criteria.

Treatment Options for Blepharitis

Blepharitis is a common eye condition that causes inflammation of the eyelids. The most appropriate first-line treatment for blepharitis is self-care measures such as eyelid hygiene and warm compresses. This involves cleaning the eyelids with warm water and a diluted cleanser such as baby shampoo twice a day, and applying a warm compress to the closed eyelids for 5-10 minutes once or twice a day.

Topical steroids are not recommended for the treatment of blepharitis, but may be used by secondary care clinicians to reduce inflammation. Topical chloramphenicol may be prescribed for anterior blepharitis if eyelid hygiene and warm compresses are ineffective, while oral tetracycline may be prescribed for posterior blepharitis with meibomian gland dysfunction and rosacea if self-care measures are ineffective.

It is important to note that topical ketoconazole is not recommended for the treatment of blepharitis, as it is used for other conditions such as fungal skin infections and candidiasis. If self-care measures and prescribed treatments do not improve symptoms, further treatment or referral may be recommended.

The GCS score for this patient is 654, which can be remembered as MoVE. This scoring system assesses the patient’s level of consciousness by evaluating their eye opening, verbal response, and motor function. In this case, the patient’s eyes are closed but will open in response to pain, earning a score of 2 out of 4. The patient is unable to speak but makes a groaning sound, earning a score of 2 out of 5. The patient also flexes in response to pain, earning a score of 4 out of 6. GCS scores are regularly monitored in patients with head injuries to detect any changes in their neurological status, which could indicate swelling or bleeding.

Understanding the Glasgow Coma Scale for Adults

The Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness in adults who have suffered a brain injury or other neurological condition. It is based on three components: motor response, verbal response, and eye opening. Each component is scored on a scale from 1 to 6, with a higher score indicating a better level of consciousness.

The motor response component assesses the patient’s ability to move in response to stimuli. A score of 6 indicates that the patient is able to obey commands, while a score of 1 indicates no movement at all.

The verbal response component assesses the patient’s ability to communicate. A score of 5 indicates that the patient is fully oriented, while a score of 1 indicates no verbal response at all.

The eye opening component assesses the patient’s ability to open their eyes. A score of 4 indicates that the patient is able to open their eyes spontaneously, while a score of 1 indicates no eye opening at all.

The GCS score is expressed as a combination of the scores from each component, with the motor response score listed first, followed by the verbal response score, and then the eye opening score. For example, a GCS score of 13, M5 V4 E4 at 21:30 would indicate that the patient had a motor response score of 5, a verbal response score of 4, and an eye opening score of 4 at 9:30 PM.

Overall, the Glasgow Coma Scale is a useful tool for healthcare professionals to assess the level of consciousness in adults with neurological conditions.

The PESI score is suggested by BTS guidelines for identifying patients with pulmonary embolism who can be treated as outpatients. It predicts long-term morbidity and mortality in PE patients. The ABCD2 is used for triaging acute Transient Ischaemic Attack cases. The CHA2DS2-VASc score aids in deciding whether to start prophylactic anticoagulation in atrial fibrillation patients. The GRACE score estimates mortality in those who have had Acute Coronary Syndrome.

Management of Pulmonary Embolism: NICE Guidelines

Pulmonary embolism (PE) is a serious condition that requires prompt management. The National Institute for Health and Care Excellence (NICE) updated their guidelines on the management of venous thromboembolism (VTE) in 2020, with some key changes. One of the significant changes is the recommendation to use direct oral anticoagulants (DOACs) as the first-line treatment for most people with VTE, including those with active cancer. Another change is the increasing use of outpatient treatment for low-risk PE patients, determined by a validated risk stratification tool.

Anticoagulant therapy is the cornerstone of VTE management, and the guidelines recommend using apixaban or rivaroxaban as the first-line treatment following the diagnosis of a PE. If neither of these is suitable, LMWH followed by dabigatran or edoxaban or LMWH followed by a vitamin K antagonist (VKA) can be used. For patients with active cancer, DOACs are now recommended instead of LMWH. The length of anticoagulation is determined by whether the VTE was provoked or unprovoked, with treatment typically stopped after 3-6 months for provoked VTE and continued for up to 6 months for unprovoked VTE.

In cases of haemodynamic instability, thrombolysis is recommended as the first-line treatment for massive PE with circulatory failure. Patients who have repeat pulmonary embolisms, despite adequate anticoagulation, may be considered for inferior vena cava (IVC) filters. However, the evidence base for IVC filter use is weak.

Overall, the updated NICE guidelines provide clear recommendations for the management of PE, including the use of DOACs as first-line treatment and outpatient management for low-risk patients. The guidelines also emphasize the importance of individualized treatment based on risk stratification and balancing the risks of VTE recurrence and bleeding.

Biliary colic is a common symptom of gallstones, occurring in 1-4% of patients with choledocholithiasis. The pain is intense and dull, usually resolving within 30-90 minutes, and often occurs after consuming fatty meals. This matches the patient’s symptoms and risk factors. If left untreated, biliary colic can progress to acute cholecystitis, which presents with upper abdominal pain, nausea, vomiting, and fever. However, since the patient’s symptoms resolved within 24 hours, acute cholecystitis is unlikely. Acute viral hepatitis is also an unlikely diagnosis, as the patient has no known exposure to the viruses and her symptoms resolved too quickly. Acute pancreatitis presents with severe abdominal pain, nausea, vomiting, and fever, which does not match the patient’s symptoms. Ascending cholangitis is also unlikely, as the patient is afebrile and not jaundiced, and her symptoms resolved within 24 hours.

Common Causes of Renal Dysfunction and Their Clinical Features

Renal dysfunction can have various causes, and identifying the underlying condition is crucial for appropriate management. Here are some common causes of renal dysfunction and their clinical features:

Renal artery stenosis (RAS): RAS can lead to renovascular hypertension and renal impairment, especially in older individuals with atherosclerosis or diabetes mellitus. Symptoms may include sudden worsening of hypertension or renal function, and ultrasonography may show kidney size asymmetry. Treatment options include pharmacologic control of hypertension and serum cholesterol levels, as well as surgical or percutaneous revascularisation in selected cases.

Membranous nephropathy: This is a type of nephrotic syndrome that often presents with oedema and significant proteinuria (>3.5 g/24 h). It is more common in adults and may be asymptomatic in some cases.

Cholesterol emboli syndrome: This condition may occur after an invasive arterial procedure and is characterised by renal dysfunction, hypertension, and distal ischaemia due to small-vessel occlusion. Livedo reticularis and blue toe syndrome may also be present.

Diabetic glomerulosclerosis: This is a complication of diabetes mellitus that can cause persistent albuminuria, declining glomerular filtration rate, and elevated blood pressure. Physical findings associated with long-term diabetes may also be present.

Reflux nephropathy: This condition is caused by the backflow of urine from the bladder to the kidneys and can lead to renal scarring. It is more common in children with urinary tract abnormalities but can also occur in adults with bladder outlet obstruction or neurogenic bladder. Symptoms may include nephrotic syndrome and urinary tract infection.

In summary, renal dysfunction can have diverse causes and presentations, and a thorough evaluation is necessary to establish the diagnosis and guide appropriate treatment.

The copper intrauterine device is the recommended form of contraception for individuals with breast cancer. Hormonal forms of contraception are not recommended and are rated as a Category 4 risk, which is deemed unacceptable for the patient’s health.

The decision to prescribe the combined oral contraceptive pill is now based on the UK Medical Eligibility Criteria (UKMEC), which categorizes potential contraindications and cautions on a four-point scale. UKMEC 1 indicates no restrictions for use, while UKMEC 2 suggests that the benefits outweigh the risks. UKMEC 3 indicates that the disadvantages may outweigh the advantages, and UKMEC 4 represents an unacceptable health risk. Examples of UKMEC 3 conditions include controlled hypertension, a family history of thromboembolic disease in first-degree relatives under 45 years old, and current gallbladder disease. Examples of UKMEC 4 conditions include a history of thromboembolic disease or thrombogenic mutation, breast cancer, and uncontrolled hypertension. Diabetes mellitus diagnosed over 20 years ago is classified as UKMEC 3 or 4 depending on severity. In 2016, breast feeding between 6 weeks and 6 months postpartum was changed from UKMEC 3 to UKMEC 2.

Managing Infantile Colic: Supportive Advice and Reassurance

Infantile colic can be a challenging condition for both parents and babies. While there is little evidence for treating colic, there are some strategies that can help manage the symptoms. Nursing the baby upright after feeds, bathing the infant in warm water, using white noise, gentle movement of baby, eg rocking the crib, holding baby during an episode, winding well and offering reassurance when needed can all be helpful.

However, it’s important to note that medications such as Infacol, Colief, Gaviscon, and Ranitidine are not recommended as first-line treatments due to lack of evidence. Maternal diet modification, probiotic supplements, herbal supplements, and manipulative strategies are also not recommended.

If your baby is experiencing colic, know that you are not alone and that supportive advice and reassurance can go a long way in managing the symptoms.

Verapamil is contraindicated in ventricular tachycardia, which is the most probable diagnosis.

Managing Ventricular Tachycardia

Ventricular tachycardia is a type of rapid heartbeat that originates in the ventricles of the heart. In a peri-arrest situation, it is assumed to be ventricular in origin. If the patient shows adverse signs such as low blood pressure, chest pain, heart failure, or syncope, immediate cardioversion is necessary. However, in the absence of such signs, antiarrhythmic drugs may be used. If drug therapy fails, electrical cardioversion may be needed with synchronised DC shocks.

There are several drugs that can be used to manage ventricular tachycardia, including amiodarone, lidocaine, and procainamide. Amiodarone is ideally administered through a central line, while lidocaine should be used with caution in severe left ventricular impairment. Verapamil should not be used in VT. If drug therapy fails, an electrophysiological study (EPS) may be conducted, or an implantable cardioverter-defibrillator (ICD) may be implanted. The ICD is particularly indicated in patients with significantly impaired LV function.

Differentiating Behçet Syndrome from Other Rheumatic Diseases

Behçet syndrome is a rare inflammatory disorder that is most commonly seen in Turkey, Iran, and Japan. It is characterized by recurrent oral ulceration and can also involve the eyes, skin, joints, and other organs. Diagnosis is based on international criteria that require oral ulceration plus any two of genital ulcers, defined eye lesions, defined skin lesions, or a positive skin pathergy test. Treatment involves corticosteroids, immunosuppressants, and other medications.

It is important to differentiate Behçet syndrome from other rheumatic diseases that can present with similar symptoms. Familial Mediterranean fever is another rare genetic disorder that can cause recurrent fever, arthritis, and serositis, but it typically affects different ethnic groups and has a different pattern of symptoms. Polyarteritis nodosa is a type of vasculitis that can cause systemic inflammation and damage to blood vessels, but it typically presents with different symptoms than Behçet syndrome. Reactive arthritis is a type of arthritis that can occur after a bacterial infection, but it typically involves urethritis and conjunctivitis in addition to joint pain. Palindromic rheumatism is a rare type of arthritis that involves sudden attacks of joint pain, but it typically does not cause lasting joint damage.

By carefully considering the patient’s symptoms and medical history, healthcare providers can make an accurate diagnosis and provide appropriate treatment for patients with Behçet syndrome and other rheumatic diseases.

Using the FeverPAIN Score to Determine Antibiotic Use for Pharyngitis

When a patient presents with symptoms of pharyngitis, it can be difficult to determine whether antibiotics are necessary. The FeverPAIN Score for Streptococcus pharyngitis was developed to help assess which patients have streptococcal pharyngitis and therefore require antibiotics.

The score assigns points based on the presence of fever, pus, quick attenuation of symptoms, inflamed tonsils, and cough.
Fever PAIN score
Fever – 1
Pus – 1
Attenuates quickly – 1
Inflamed tonsils – 1
No cough – 1
A score of 0-1 is associated with a low likelihood of streptococcal infection and does not require antibiotics. A score of 2-3 may warrant a delayed antibiotic prescription, while a score of 4 or more may require immediate antibiotics.

In the case of a patient with a low FeverPAIN score, it is important to advise against antibiotics and instead recommend a follow-up visit in one week if there is no improvement. Safety netting should also be provided to ensure the patient is aware of potential warning signs of deterioration. By using the FeverPAIN score, healthcare providers can reduce inappropriate antibiotic use in pharyngitis and promote more effective treatment.

Triptan use is contraindicated in individuals with cardiovascular disease.

Triptans for Migraine Treatment

Triptans are medications that act as agonists for 5-HT1B and 5-HT1D receptors and are commonly used in the acute treatment of migraines. They are often prescribed in combination with NSAIDs or paracetamol and are typically taken as soon as possible after the onset of a headache, rather than at the onset of an aura. Triptans are available in various forms, including oral tablets, orodispersible tablets, nasal sprays, and subcutaneous injections.

While triptans are generally well-tolerated, some patients may experience triptan sensations, such as tingling, heat, tightness in the throat and chest, heaviness, or pressure. It is important to note that triptans are contraindicated in patients with a history of or significant risk factors for ischaemic heart disease or cerebrovascular disease.

In summary, triptans are a commonly used medication for the acute treatment of migraines. They should be taken as soon as possible after the onset of a headache and are available in various forms. However, patients should be aware of potential adverse effects and contraindications before taking triptans.

Alcoholic Liver Disease: Facts and Myths

Alcoholic liver disease (ALD) is a common liver disease caused by overconsumption of alcohol. Here are some facts and myths about ALD:

Myth: In alcoholic hepatitis, the AST:ALT ratio is less than 2:1.
Fact: Unlike most other liver diseases, including viral hepatitis, alcoholic hepatitis exhibits at least a 2:1 AST:ALT ratio.

Myth: Hepatic iron overload is not indicative of concomitant heterozygote haemochromatosis.
Fact: Evidence of iron overload, such as elevated levels of transferrin saturation and serum ferritin, is common in ALD and may indicate concomitant heterozygote haemochromatosis.

Myth: Women are less susceptible to ALD than men.
Fact: Women are actually twice as susceptible to ALD than men, even when consumption is corrected for body weight, and may develop ALD with shorter durations and doses of chronic consumption.

Myth: Alcoholic fatty infiltration is irreversible once established.
Fact: Although steatosis (fatty infiltration) will develop in any individual who consumes a large quantity of alcohol over a long period of time, this process is usually transient and reversible. Alcoholic hepatitis and alcoholic fatty infiltration are reversible with abstinence and adequate nutrition.

Myth: Alcoholic cirrhosis does not progress to hepatocellular carcinoma.
Fact: Like other causes of liver cirrhosis, alcoholic cirrhosis can also progress to hepatocellular carcinoma.

In conclusion, ALD is a serious liver disease that can have irreversible consequences if not addressed in a timely manner. It is important to understand the facts and myths surrounding this disease to ensure proper diagnosis and treatment.

The Meningitis ACWY vaccine is being gradually introduced and is recommended for all children during their 9th or 10th year of school. Instead of the Men C booster, they should receive this vaccination. The catch-up program is currently targeting individuals under the age of 25 who are starting university for the first time. It is recommended that they receive the vaccine a few weeks before beginning their studies.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at certain intervals. At 12-13 months, the Hib/Men C, MMR, and PCV vaccines are given, along with Men B. At 3-4 years, the ‘4-in-1 pre-school booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine will also be offered to new students (up to the age of 25 years) at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine. Students going to university or college for the first time as freshers, including overseas and mature students up to the age of 25, should contact their GP to have the Men ACWY vaccine, ideally before the start of the academic year.

It is worth noting that the Men C vaccine used to be given at 3 months but has now been discontinued. This is because the success of the Men C vaccination programme means there are almost no cases of Men C disease in babies or young children in the UK any longer. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Performing airway suction should be avoided unless there is clear evidence of thick meconium causing obstruction, as it may lead to reflex bradycardia in infants. Chest compressions are not necessary if the heart rate (HR) is above 100 beats per minute (bpm). CPR should only be initiated if the HR drops below 60 bpm. If there are no signs of breathing due to fluid in the lungs, administering five breaths through a 250ml ambu bag is a more effective and hygienic approach than using mouth-to-mouth resuscitation in a hospital setting.

The Apgar score is a tool used to evaluate the health of a newborn baby. It is recommended by NICE to be assessed at 1 and 5 minutes after birth, and again at 10 minutes if the initial score is low. The score is based on five factors: pulse, respiratory effort, color, muscle tone, and reflex irritability. A score of 0-3 is considered very low, 4-6 is moderate low, and 7-10 indicates that the baby is in good health. The score helps healthcare professionals quickly identify any potential issues and provide appropriate care.

According to the updated 2018 NICE guidelines, the initial test for patients with suspected chronic heart failure should be an NT-proBNP test, regardless of their history of myocardial infarction. Additionally, all patients should undergo a 12-lead ECG. While a CT chest is typically not necessary, a chest x-ray may be performed to rule out other potential conditions.

Chronic heart failure is a condition that requires proper diagnosis and management. In 2018, NICE updated their guidelines on the diagnosis and management of this condition. Previously, the first-line investigation was determined by whether the patient had previously had a myocardial infarction or not. However, this is no longer the case. All patients should now have an N-terminal pro-B-type natriuretic peptide (NT‑proBNP) blood test as the first-line investigation.

Interpreting the NT-proBNP blood test is crucial in determining the severity of the condition. If the levels are high, specialist assessment, including transthoracic echocardiography, should be arranged within two weeks. If the levels are raised, specialist assessment, including echocardiogram, should be arranged within six weeks. B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to strain. Very high levels of BNP are associated with a poor prognosis.

There are different levels of BNP, and each level indicates a different severity of the condition. High levels of BNP are greater than 400 pg/ml (116 pmol/litre) for BNP and greater than 2000 pg/ml (236 pmol/litre) for NTproBNP. Raised levels of BNP are between 100-400 pg/ml (29-116 pmol/litre) for BNP and between 400-2000 pg/ml (47-236 pmol/litre) for NTproBNP. Normal levels of BNP are less than 100 pg/ml (29 pmol/litre) for BNP and less than 400 pg/ml (47 pmol/litre) for NTproBNP.

It is important to note that several factors can alter the BNP level. Factors that increase BNP levels include left ventricular hypertrophy, ischaemia, tachycardia, right ventricular overload, hypoxaemia (including pulmonary embolism), GFR < 60 ml/min, sepsis, COPD, diabetes, and age > 70. On the other hand, factors that decrease BNP levels include diuretics, ACE inhibitors, beta-blockers, angiotensin 2 receptor blockers, and aldosterone antagonists.

Category 2 caesarean sections should be performed within 75 minutes of the decision being made. This is because these cases involve maternal or fetal compromise that is not immediately life-threatening, allowing the medical team to manage the emergency and plan the surgery to minimize risks to both the mother and the baby. A timeframe of 2 hours is incorrect as it would delay the necessary intervention. On the other hand, a timeframe of 30 minutes is only applicable to category 1 caesarean sections, where there is an immediate threat to the life of the mother or baby. A timeframe of 5 minutes is too short and may increase the risk of errors during the procedure.

Caesarean Section: Types, Indications, and Risks

Caesarean section, also known as C-section, is a surgical procedure that involves delivering a baby through an incision in the mother’s abdomen and uterus. In recent years, the rate of C-section has increased significantly due to an increased fear of litigation. There are two main types of C-section: lower segment C-section, which comprises 99% of cases, and classic C-section, which involves a longitudinal incision in the upper segment of the uterus.

C-section may be indicated for various reasons, including absolute cephalopelvic disproportion, placenta praevia grades 3/4, pre-eclampsia, post-maturity, IUGR, fetal distress in labor/prolapsed cord, failure of labor to progress, malpresentations, placental abruption, vaginal infection, and cervical cancer. The urgency of C-section may be categorized into four categories, with Category 1 being the most urgent and Category 4 being elective.

It is important for clinicians to inform women of the serious and frequent risks associated with C-section, including emergency hysterectomy, need for further surgery, admission to intensive care unit, thromboembolic disease, bladder injury, ureteric injury, and death. C-section may also increase the risk of uterine rupture, antepartum stillbirth, placenta praevia, and placenta accreta in subsequent pregnancies. Other complications may include persistent wound and abdominal discomfort, increased risk of repeat C-section, readmission to hospital, haemorrhage, infection, and fetal lacerations.

Vaginal birth after C-section (VBAC) may be an appropriate method of delivery for pregnant women with a single previous C-section delivery, except for those with previous uterine rupture or classical C-section scar. The success rate of VBAC is around 70-75%.

A thickened brown velvety patch of skin, often accompanied by skin tags, is a common sign of Acanthosis nigricans (AN). This condition is typically found in the axilla, groin, and back of the neck. However, AN is not a standalone condition, but rather a cutaneous sign of underlying disease. The most common type of AN is associated with obesity and insulin resistance. Other underlying conditions linked to AN include Cushing’s syndrome, polycystic ovary syndrome, and certain medications such as nicotinic acid, insulin, and systemic corticosteroids. In rare cases, AN may indicate an underlying malignancy, particularly stomach cancer. Therefore, it is crucial to consider this possibility when making a diagnosis.

Acanthosis nigricans is a condition characterized by the presence of symmetrical, brown, velvety plaques on the neck, axilla, and groin. This condition can be caused by various factors such as type 2 diabetes mellitus, gastrointestinal cancer, obesity, polycystic ovarian syndrome, acromegaly, Cushing’s disease, hypothyroidism, familial factors, Prader-Willi syndrome, and certain drugs like the combined oral contraceptive pill and nicotinic acid. The pathophysiology of acanthosis nigricans involves insulin resistance, which leads to hyperinsulinemia. This, in turn, stimulates the proliferation of keratinocytes and dermal fibroblasts through interaction with insulin-like growth factor receptor-1 (IGFR1).

Blistering is not a characteristic of polymorphic eruption of pregnancy.

Skin Disorders Associated with Pregnancy

During pregnancy, women may experience various skin disorders. The most common one is atopic eruption of pregnancy, which is characterized by an itchy red rash. This condition does not require any specific treatment. Another skin disorder is polymorphic eruption of pregnancy, which is a pruritic condition that usually appears during the last trimester. The lesions often first appear in abdominal striae, and management depends on the severity of the condition. Emollients, mild potency topical steroids, and oral steroids may be used. Pemphigoid gestationis is another skin disorder that causes pruritic blistering lesions. It usually develops in the peri-umbilical region and later spreads to the trunk, back, buttocks, and arms. This condition is rarely seen in the first pregnancy and usually presents in the second or third trimester. Oral corticosteroids are usually required for treatment.

Endocrine Disorders: Congenital Adrenal Hyperplasia, Conn Syndrome, Addisonian Crisis, Cushing Syndrome, and Thyrotoxic Crisis

Endocrine disorders are conditions that affect the production and regulation of hormones in the body. Here are five different endocrine disorders and their characteristics:

Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive conditions caused by mutations in the enzymes involved in the production of steroids and hormones from the adrenal glands. It can affect both men and women equally, and symptoms include ambiguous genitalia at birth for women and hyperpigmentation and penile enlargement for men. Treatment involves hormone replacement therapy.

Conn Syndrome is a condition associated with primary hyperaldosteronism, which presents with hypernatraemia and hypokalaemia. It is more commonly seen in adult patients, but there are cases reported in childhood.

Addisonian Crisis occurs due to glucocorticoid and mineralocorticoid deficiency, usually occurring in adulthood. It is a potentially fatal episode that presents with hyponatraemia, hyperkalaemia, hypoglycaemia, and hypercalcaemia. Urgent intravenous administration of glucocorticoids is necessary for management.

Cushing Syndrome is due to cortisol excess, either exogenous or endogenous, and is usually diagnosed in adulthood. Symptoms include weight gain, hypertension, oedema, hyperglycaemia, hypokalaemia, and pigmentation of the skin in the axillae and neck.

Thyrotoxic Crisis, also known as a thyroid storm, is a life-threatening condition associated with excessive production of thyroid hormones. It can be the first presentation of undiagnosed hyperthyroidism in neonates and children. Symptoms include tachycardia, hypertension, fever, poor feeding, weight loss, diarrhoea, nausea, vomiting, seizures, and coma. Prompt treatment is necessary to prevent acute congestive heart failure, shock, and death.

The sudden painless loss of vision described in the history is most likely caused by retinal detachment. The classic symptom of a dense shadow starting from the periphery and progressing towards the center, along with the patient’s history of myopia, are highly suggestive of this condition. Urgent corrective surgery is necessary to address this issue.

Central retinal artery occlusion is less likely to be the diagnosis as there are no risk factors mentioned for thromboembolism or arteritis. Similarly, central retinal vein occlusion is a possibility but given the lack of risk factors and the patient’s history, retinal detachment is still the more likely cause.

It is important to note that vitreous detachment is not a direct cause of vision loss, although it may precede retinal detachment. Its symptoms typically involve floaters or flashes of light that do not usually interfere with daily activities.

Sudden loss of vision can be a scary symptom for patients, as it may indicate a serious issue or only be temporary. Transient monocular visual loss (TMVL) is a term used to describe a sudden, brief loss of vision that lasts less than 24 hours. The most common causes of sudden, painless loss of vision include ischaemic/vascular issues (such as thrombosis, embolism, and temporal arteritis), vitreous haemorrhage, retinal detachment, and retinal migraine.

Ischaemic/vascular issues, also known as ‘amaurosis fugax’, have a wide range of potential causes, including large artery disease, small artery occlusive disease, venous disease, and hypoperfusion. Altitudinal field defects are often seen, and ischaemic optic neuropathy can occur due to occlusion of the short posterior ciliary arteries. Central retinal vein occlusion is more common than arterial occlusion and can be caused by glaucoma, polycythaemia, or hypertension. Central retinal artery occlusion is typically caused by thromboembolism or arteritis and may present with an afferent pupillary defect and a ‘cherry red’ spot on a pale retina.

Vitreous haemorrhage can be caused by diabetes, bleeding disorders, or anticoagulants and may present with sudden visual loss and dark spots. Retinal detachment may be preceded by flashes of light or floaters, which are also common in posterior vitreous detachment. Differentiating between posterior vitreous detachment, retinal detachment, and vitreous haemorrhage can be challenging, but each has distinct features such as photopsia and floaters for posterior vitreous detachment, a dense shadow that progresses towards central vision for retinal detachment, and large bleeds causing sudden visual loss for vitreous haemorrhage.

Common Viral Infections: Symptoms and Characteristics

Infectious mononucleosis, also known as the kissing disease, is caused by the Epstein-Barr virus and is characterized by fever, pharyngitis, and adenopathy. It is primarily transmitted through intimate contact with body secretions, particularly oropharyngeal secretions. Pharyngitis is caused by the proliferation of infected B lymphocytes in the lymphatic tissue of the oropharynx. It is most common in young adults and can be mistaken for streptococcal pharyngitis.

German measles, or rubella, is a communicable exanthematous disease that is generally benign. However, pregnant women who contract the disease in the early weeks of gestation can experience teratogenic effects. The exanthema of rubella consists of a rose-pink maculopapular rash that starts on the face and neck and spreads to the trunk and extremities within 24 hours. It typically fades by the end of the third day.

Chickenpox is a childhood illness caused by the varicella-zoster virus. It is characterized by a vesicular exanthem and is typically self-limited and mild.

Herpes simplex viruses are host-adapted pathogens that cause a wide variety of disease states. HSV-1 is associated with orofacial disease, while HSV-2 is associated with genital disease. Oropharyngeal HSV-1 infection causes pharyngitis and tonsillitis more often than gingivostomatitis. Herpes labialis, or cold sores, is the most common manifestation of recurrent HSV-1 infection.

Cytomegalovirus (CMV) infection is prevalent in developed countries, with at least 60% of the population having been exposed. It typically causes an asymptomatic infection or produces mild flu-like symptoms, with few clinical findings on physical examination. High-risk groups, such as fetuses whose mothers become infected during pregnancy or people with HIV, are more susceptible to severe complications.

Overview of Common Viral Infections and Their Characteristics

Understanding HLA Typing and Graft Failure in Renal Transplants

The human leucocyte antigen (HLA) system, also known as the major histocompatibility complex (MHC), is located on chromosome 6 and plays a crucial role in renal transplants. The HLA system includes class 1 antigens (A, B, and C) and class 2 antigens (DP, DQ, and DR), with DR being the most important for HLA matching in renal transplants. Graft survival rates for cadaveric transplants are 90% at 1 year and 60% at 10 years, while living-donor transplants have a 95% survival rate at 1 year and 70% at 10 years.

Post-operative problems may include acute tubular necrosis of the graft, vascular thrombosis, urine leakage, and urinary tract infections. Hyperacute rejection, which occurs within minutes to hours, is caused by pre-existing antibodies against ABO or HLA antigens and leads to widespread thrombosis of graft vessels, resulting in the need for graft removal. Acute graft failure, which occurs within 6 months, is usually due to mismatched HLA and is picked up by a rising creatinine, pyuria, and proteinuria. Chronic graft failure, which occurs after 6 months, is caused by both antibody and cell-mediated mechanisms and leads to fibrosis of the transplanted kidney, with recurrence of the original renal disease being a common cause.

In summary, understanding the HLA system and its role in renal transplants is crucial for successful outcomes. Monitoring for post-operative problems and early detection of graft failure can help improve long-term survival rates.